Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if ZOETIS INC (NYSE:ZTS) is suited for quality investing. Investors should of course do their own research, but we spotted ZOETIS INC showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.
Key Considerations for Quality Investors.
ZOETIS INC has shown strong performance in revenue growth over the past 5 years, with a 8.77% increase. This indicates the company's ability to generate consistent revenue growth and reflects its potential for long-term success.
With a notable ROIC excluding cash and goodwill at 37.77%, ZOETIS INC demonstrates its commitment to generating sustainable returns for shareholders. This metric emphasizes the company's effective use of capital and its ability to deliver long-term value.
The Debt/Free Cash Flow Ratio of ZOETIS INC stands at 4.39, reflecting the company's prudent capital structure and cash flow dynamics. This ratio highlights the company's ability to generate robust free cash flow relative to its debt obligations.
With a robust Profit Quality (5-year) ratio of 88.15%, ZOETIS INC highlights its ability to consistently generate high-quality profits. This metric reflects the company's effective management and operational excellence in delivering reliable earnings over the long term.
The 5-year EBIT growth of ZOETIS INC has been remarkable, with 11.0% increase. This demonstrates the company's ability to improve its operational efficiency and indicates its competitiveness within the market.
The EBIT 5-year growth of ZOETIS INC has outpaced its Revenue 5-year growth, reflecting the company's focus on optimizing its profitability and generating sustainable earnings. This trend underscores its strong financial management.
What is the full fundamental picture of NYSE:ZTS telling us.
As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.
ZTS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 204 industry peers in the Pharmaceuticals industry. ZTS gets an excellent profitability rating and is at the same time showing great financial health properties. ZTS is not valued too expensively and it also shows a decent growth rate. These ratings could make ZTS a good candidate for quality investing.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.